Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04363944 · ClinicalTrials.gov registry record · NA

Smartphone and 3D Printing Based Home Rehabilitation System for Chronic Stroke

A NA study of Stroke, sponsored by State University of New York at Buffalo.

Completed
Registry status
NA
Development phase
19
Enrollment target
1
Study location

NCT04363944 is a NA study of Stroke that has completed, run by State University of New York at Buffalo. The registered enrollment target is 19 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04363944, a NA study of Stroke, has completed, sponsored by State University of New York at Buffalo.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

Interventions promoting optimum motor performance across the lifespan are a priority after a neurological insult such as stroke. The proposed research incorporates smart devices and 3D printing to create a patient-centered rehabilitation device, mRehab. This innovative blend of technology and principles of neuroplasticity can advance standards of practice in healthcare. In this feasibility study, it is hypothesized that individuals with chronic stroke can successfully use the portable rehabilitation unit, mRehab, at home with minimal oversight from the research team. Use of mRehab in a home based setting and functional changes in upper limb movement will be assessed.

Conditions Studied

Interventions

  • DEVICE mRehab

Study Locations (1)

New York

  • University at Buffalo - Buffalo

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2018-02-21
Est. Completion 2019-07-29
Phase NA

What the Registry Record Tells You About NCT04363944

The ClinicalTrials.gov registry entry for NCT04363944 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which mRehab is the first listed.

NCT04363944 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04363944 about?

NCT04363944 is a clinical study titled "Smartphone and 3D Printing Based Home Rehabilitation System for Chronic Stroke". Interventions promoting optimum motor performance across the lifespan are a priority after a neurological insult such as stroke. The proposed research incorporates smart devices and 3D printing to create a patient-centered rehabilitation device, mRehab. This innovative blend of technology and princi...

What is the current status of trial NCT04363944?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2018-02-21. Estimated completion is 2019-07-29.

What conditions does trial NCT04363944 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT04363944?

The interventions under investigation include: mRehab (DEVICE).

Who is sponsoring clinical trial NCT04363944?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04363944 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.